Abstract:The role of the metalloproteinase ADAMTS4 in the generation of N‐terminally elongated Aβ peptide species has been characterized with cell‐free and cell‐based assays in combination with mass spectrometry. Immunohistochemical analysis revealed the deposition of N‐terminally elongated Ab variants in the brains of a subset of AD patients. Aims The aggregation and deposition of amyloid‐β (Aβ) peptides in the brain is thought to be the initial driver in the pathogenesis of Alzheimer's disease (AD). Aside from full‐length Aβ peptides starting with an aspartate residue in position 1, both N‐terminally truncated and elongated Aβ peptides are produced by various proteases from the amyloid precursor protein (APP) and have been detected in brain tissues and body fluids. Recently, we demonstrated that the particularly abundant N‐terminally truncated Aβ4–x peptides are generated by ADAMTS4, a secreted metalloprotease that is exclusively expressed in the oligodendrocyte cell population. In this study, we investigated whether ADAMTS4 might also be involved in the generation of N‐terminally elongated Aβ peptides. Methods We used cell‐free and cell‐based assays in combination with matrix‐assisted laser desorption/ionisation time‐of‐flight mass spectrometry (MALDI‐TOF) and electrochemiluminescence sandwich immunoassays to identify and quantify N‐terminally elongated Aβ peptide variants. Antibodies against these Aβ variants were characterised by peptide microarrays and employed for the immunohistochemical analyses of human brain samples. Results In this study, we discovered additional ADAMTS4 cleavage sites in APP. These were located N‐terminal to Asp‐(1) in the Aβ peptide sequence between residues Glu‐(‐7) and Ile‐(‐6) as well as Glu‐(‐4) and Val‐(‐3), resulting in the release of N‐terminally elongated Aβ‐6‐x and Aβ‐3‐x peptides, of which the latter serve as a component in a promising Aβ‐based plasma biomarker. Aβ‐6/‐3‐40 peptides were detected in supernatants of various cell lines and in the cerebrospinal fluid (CSF), and ADAMTS4 enzyme activity promoted the release of Aβ‐6/‐3‐x peptides. Furthermore, by immunohistochemistry, a subset of AD cases displayed evidence of extracellular and vascular localization of N‐terminally elongated Aβ‐6/‐3‐x peptides. Discussion The current findings implicate ADAMTS4 in both the pathological process of Aβ peptide aggregation and in the early detection of amyloid pathology in AD.

Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation.

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

Amino‐terminally elongated Aβ peptides are generated by the secreted metalloprotease ADAMTS4 and deposit in a subset of Alzheimer's disease brains

Copper catalyzed oxidation of alzheimer A beta

Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.

Heme-Aβ in SDS micellar environment: Active site environment and reactivity

Identification and characterization of C-terminal fragments of the beta-amyloid precursor produced in cell culture.

Modification of Amyloid-Β1-42 Fibril Structure by Methionine-35 Oxidation.

APP and β-amyloid modulate protein aggregation and dissociation from recycling endosomal and exosomal membranes

Proteolytic processing of Alzheimer's β-amyloid precursor protein.

Mutations in APP have independent effects on Abeta and CTFgamma generation.

Impact of membrane lipid composition on the structure and stability of the transmembrane domain of amyloid precursor protein

Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer’s Aβ peptides

In vitro peroxidase oxidation induces stable dimers of beta-amyloid (1-42) through dityrosine bridge formation

Truncated and Modified Aβ Species in Alzheimer's Disease

Purification and aggregation of the amyloid precursor protein intracellular domain

Longer Forms of Amyloid Β Protein: Implications for the Mechanism of Intramembrane Cleavage by Γ-Secretase

S4-03-01: Evidence That Aberrant Post-Tgn Trafficking of Alzheimer’s APP is Sufficient to Elevate Brain A-beta 42 and May Underlie Mutant Presenilin Action

The A Beta Peptide of Alzheimer'S Disease Directly Produces Hydrogen Peroxide Through Metal Ion Reduction

Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations

APP Substitutions V715F and L720P Alter PS1 Conformation and Differentially Affect Abeta and AICD Generation.